ThinkLive Insights: Expert insights for your commercialization journey
Explore the topics that matter most to manufacturers in our new video series .
At AmerisourceBergen, we know the distribution journey can be both exciting and complex. We’re excited to share our latest video series, ThinkLive Insights. Captured at our ThinkLive Trade summit in October 2022, these insights are designed to help you navigate the challenges and considerations that manufacturers face when bringing products to market, and how AmerisourceBergen can help you overcome those challenges and unlock your product’s potential.
Fireside chat: Seema Verma and Bob Mauch
Tune in as Seema Verma, national health policy expert and former Centers for Medicare and Medicaid Services (CMS) Administrator and Bob Mauch, AmerisourceBergen EVP and Chief Operating Officer, explore topics that are top-of-mind for pharmaceutical manufacturers, including the implications on drug pricing due to the Inflation Reduction Act, and how you can actively engage with CMS to make your voice heard.
What’s next from AmerisourceBergen: Modern solutions for unlocking product potential
Join AmerisourceBergen senior leaders, Willis Chandler, Jan Burkett, and Heather Zenk, for a dynamic panel discussion in which they focus on key market trends for 2023 and how AmerisourceBergen is continuing to drive excellence in trade and channel strategy, protecting the supply chain, and meeting the evolving needs of our manufacturer partners.
Executive address: Steve Collis
Hear remarks from Steve Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen during the ThinkLive Trade 2022 Summit in October.
Unpacking the Inflation Reduction Act of 2022
The Inflation Reduction Act (IRA) has generated a lot of uncertainty among pharmaceutical manufacturers — and for good reason. The healthcare provisions contain significant changes that could have far-reaching, rippling effects on the healthcare industry and its stakeholders. In this video, our AmerisourceBergen experts summarize the key elements of the new policy, the most important unknowns at this stage, and areas where manufacturers may need to reassess their strategies.
Innovation for an evolving future life
It’s clear that the pharmaceutical commercialization space is becoming more and more complex, and the industry is evolving and accelerating at a rapid pace. In this video, our AmerisourceBergen experts outline the innovative products and solutions we're working on to ensure your path to success is covered today and in the future. We’ll take a closer look at AmerisourceBergen Marketplace, an outcomes-based cell and gene therapy financial product, enhancements to CERTIO®, and our Innovation Partnership Program.